TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Alpha Teknova, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$6.80−0.28 (-3.95%)
Close on Oct 19, 2026
- Market cap
- $364.72M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
17.0%
9M of 54M shares
Institutional holders
80
12 new, 8 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
2 buys · 0 sales
Net bought $143.50K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Telegraph Hill Partners Management Company, LLC | 37,717,565 | 70.80% | 13D (active) | Jul 12, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TKNO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Royce & Associates LP | 1,661,395 | 3.09% | $9.44M | +592,233 | 0.08% |
| Vanguard Capital Management LLC | 1,614,045 | 3.01% | $9.17M | +1,172,166 | 0.00% |
| Roubaix Capital, LLC | 1,579,404 | 2.94% | $8.97M | −302,951 | 3.22% |
| BlackRock, Inc. | 879,786 | 1.64% | $5.00M | +163,012 | 0.00% |
| UBS Group AG | 631,967 | 1.18% | $3.59M | +306,804 | 0.00% |
| Conestoga Capital Advisors, LLC | 314,554 | 0.59% | $1.79M | −2,530 | 0.04% |
| Geode Capital Management, LLC | 311,818 | 0.58% | $1.77M | +3,945 | 0.00% |
| Bank Of America Corp /De/ | 255,760 | 0.48% | $1.45M | +27,474 | 0.00% |
| Goldman Sachs Group Inc | 172,017 | 0.32% | $977.06K | +53,578 | 0.00% |
| State Street Corp | 164,885 | 0.31% | $936.55K | +9,796 | 0.00% |
| Aqr Capital Management LLC | 113,774 | 0.21% | $646.24K | +47,369 | 0.00% |
| Bank of New York Mellon Corp | 106,420 | 0.20% | $604.47K | +6,451 | 0.00% |
| Vanguard Fiduciary Trust Co | 103,467 | 0.19% | $587.69K | +28,378 | 0.00% |
| Morgan Stanley | 98,799 | 0.18% | $561.18K | −18,191 | 0.00% |
| Northern Trust Corp | 90,214 | 0.17% | $512.42K | −5,764 | 0.00% |
| Bridgeway Capital Management, LLC | 80,900 | 0.15% | $459.51K | +25,000 | 0.01% |
| Divisadero Street Capital Management, LP | 78,872 | 0.15% | $447.99K | – | 0.01% |
| Vanguard Portfolio Management LLC | 76,062 | 0.14% | $432.03K | +11,551 | 0.00% |
| Millennium Management LLC | 74,966 | 0.14% | $425.81K | −372,172 | 0.00% |
| Wells Fargo & Company/Mn | 69,225 | 0.13% | $393.20K | +65,275 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 80 | 9M | 17.0% | 12 / 35 | 19 / 8 | 3M | 1M |
| Q1 2026 | 78 | 8M | 14.2% | 23 / 24 | 20 / 13 | 3M | 2M |
| Q4 2025 | 70 | 7M | 13.0% | 12 / 23 | 20 / 10 | 1M | 1M |
| Q3 2025 | 68 | 7M | 13.9% | 13 / 19 | 22 / 13 | 1M | 1M |
| Q2 2025 | 68 | 8M | 14.3% | 24 / 27 | 7 / 21 | 3M | 1M |
| Q1 2025 | 65 | 6M | 11.5% | 26 / 15 | 20 / 8 | 2M | 2M |
| Q4 2024 | 47 | 6M | 11.9% | 22 / 13 | 9 / 7 | 3M | 2M |
| Q3 2024 | 32 | 5M | 9.6% | 11 / 11 | 9 / 6 | 2M | 2M |
| Q2 2024 | 28 | 6M | 10.9% | 2 / 9 | 12 / 5 | 0M | 1M |
| Q1 2024 | 31 | 6M | 11.5% | 3 / 15 | 6 / 3 | 1M | 0M |
| Q4 2023 | 31 | 6M | 10.7% | 5 / 12 | 9 / 2 | 1M | 0M |
| Q3 2023 | 28 | 5M | 9.7% | 2 / 8 | 13 / 5 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TKNO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,477,356 | 2.75% | $8.39M | 0.00% | Jun 30, 2026 |
| Royce Micro-Cap Fund | 467,232 | 0.87% | $2.65M | 0.62% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 305,824 | 0.57% | $1.74M | 0.00% | Jun 30, 2026 |
| Royce Capital Fund - Micro-Cap Portfolio | 150,230 | 0.28% | $853.31K | 0.61% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 122,765 | 0.23% | $613.83K | 0.00% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 113,404 | 0.21% | $644.13K | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 96,258 | 0.18% | $546.75K | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 79,753 | 0.15% | $453.00K | 0.00% | Jun 30, 2026 |
| iShares Biotechnology ETF | 77,165 | 0.14% | $438.30K | 0.00% | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 75,000 | 0.14% | $426.00K | 0.29% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 67,054 | 0.12% | $362.09K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 55,634 | 0.10% | $300.42K | 0.00% | May 31, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 42,355 | 0.08% | $240.58K | 0.00% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 37,732 | 0.07% | $214.32K | 0.01% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 34,865 | 0.06% | $188.27K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Stephen Gunstream | President and CEO, Director | 269,497 | 0.50% | Mar 9, 2026 |
| Matthew Lowell | Chief Financial Officer | 168,376 | 0.31% | Mar 9, 2026 |
| Damon Terrill | General Counsel and CCO | 41,027 | 0.08% | Mar 9, 2026 |
| Martha J. Demski | Director | 12,000 | 0.02% | Jul 16, 2026 |
| Alexander Vos | Director | 102,472 | 0.19% | Jun 2, 2026 |
| Brett Robertson | Director | 107,472 | 0.20% | Jun 2, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Martha J. Demski Director | Jul 14, 2026 | Other | +12,000 | – | – | 12,000 |
| Martha J. Demski Director | Jul 14, 2026 | Other | −12,000 | – | – | 0 |
| Matthew Lowell Chief Financial Officer | Mar 6, 2026 | Buy | +40,000 | $2.19 | $87.60K | 168,376 |
| Stephen Gunstream President and CEO, Director | Mar 6, 2026 | Buy | +26,000 | $2.15 | $55.90K | 269,497 |
| Martha J. Demski Director | Jun 27, 2025 | Sale(10b5-1 plan) | −8,000 | $5.06 | $40.48K | 12,000 |
| Brett Robertson Director | Jun 17, 2025 | Award | +54,300 | – | – | 102,472 |
| Alexander Vos Director | Jun 17, 2025 | Award | +54,300 | – | – | 102,472 |
| Martha J. Demski Director | Jun 17, 2025 | Award | +54,300 | – | – | 74,300 |
| Brett Robertson Director | Feb 27, 2025 | Other | +5,000 | – | – | 5,000 |
| Telegraph Hill Partners IV, L.P. 10% owner | Jul 12, 2024 | Buy | +969,844 | $1.24 | $1.20M | 969,844 |
| Telegraph Hill Partners IV, L.P. 10% owner | Jul 12, 2024 | Buy | +11,126,929 | $1.24 | $13.80M | 11,126,929 |
| Stephen Gunstream President and CEO, Director | Jul 12, 2024 | Buy | +80,645 | $1.24 | $100.00K | 243,497 |
| Matthew Lowell Chief Financial Officer | Jul 12, 2024 | Buy | +40,322 | $1.24 | $50.00K | 128,376 |
| Alexander Vos Director | Jun 26, 2024 | Award | +20,000 | – | – | 48,172 |
| Brett Robertson Director | Jun 26, 2024 | Award | +20,000 | – | – | 48,172 |
| Martha J. Demski Director | Jun 26, 2024 | Award | +20,000 | – | – | 20,000 |
| Ken Gelhaus Chief Commercial Officer | Nov 30, 2023 | Buy | +3,587 | $1.73 | $6.21K | 22,924 |
| Lisa Hood Chief People Officer | Nov 14, 2023 | Other | −15,000 | – | – | 18,834 |
| Matthew Lowell Chief Financial Officer | Sep 19, 2023 | Buy | +54,054 | $1.85 | $100.00K | 88,054 |
| J. Matthew Mackowski Director | Sep 19, 2023 | Buy | +810,810 | $1.85 | $1.50M | 810,810 |
| Telegraph Hill Partners Management Company, LLC 10% owner | Sep 19, 2023 | Buy | +1,190,270 | $1.85 | $2.20M | 3,761,132 |
| Telegraph Hill Partners Management Company, LLC 10% owner | Sep 19, 2023 | Buy | +6,917,837 | $1.85 | $12.80M | 21,859,660 |
| Damon Terrill General Counsel and CCO | Sep 19, 2023 | Buy | +27,027 | $1.85 | $50.00K | 41,027 |
| Stephen Gunstream President and CEO, Director | Sep 19, 2023 | Buy | +54,054 | $1.85 | $100.00K | 162,852 |
| Robert McNamara Director | Aug 31, 2023 | Returned to company | −18,815 | – | – | 9,357 |
| Lisa Hood Chief People Officer | Jun 13, 2023 | Sale | −11,400 | $3.80 | $43.32K | 33,834 |
| Robert McNamara Director | Jun 2, 2023 | Award | +18,815 | – | – | 28,172 |
| Alexander Vos Director | Jun 2, 2023 | Award | +18,815 | – | – | 28,172 |
| Brett Robertson Director | Jun 2, 2023 | Award | +18,815 | – | – | 28,172 |
| Ted Davis Director, 10% owner | May 26, 2023 | Buy | +1,000 | $3.17 | $3.17K | 1,888,419 |
| Ted Davis Director, 10% owner | May 26, 2023 | Buy | +1,000 | $3.26 | $3.26K | 1,887,419 |
| Irene Davis Director, 10% owner | May 26, 2023 | Buy | +1,000 | $3.17 | $3.17K | 1,888,419 |
| Irene Davis Director, 10% owner | May 26, 2023 | Buy | +1,000 | $3.26 | $3.26K | 1,887,419 |
| Lisa Hood Chief People Officer | May 17, 2023 | Sale | −3,119 | $2.04 | $6.36K | 45,234 |
| Ken Gelhaus Chief Commercial Officer | May 12, 2023 | Buy | +3,915 | $1.67 | $6.54K | 19,337 |
| Stephen Gunstream President and CEO, Director | May 12, 2023 | Buy | +4,665 | $1.67 | $7.79K | 108,798 |
| Lisa Hood Chief People Officer | May 12, 2023 | Buy | +3,119 | $1.67 | $5.21K | 48,353 |
| Ken Gelhaus Chief Commercial Officer | Feb 27, 2023 | Award | +14,000 | – | – | 15,422 |
| Lisa Hood Chief People Officer | Feb 27, 2023 | Award | +14,000 | – | – | 45,234 |
| Matthew Lowell Chief Financial Officer | Feb 27, 2023 | Award | +14,000 | – | – | 34,000 |
| Damon Terrill General Counsel and CCO | Feb 27, 2023 | Award | +14,000 | – | – | 14,000 |
| Stephen Gunstream President and CEO, Director | Feb 27, 2023 | Award | +43,125 | – | – | 104,133 |
| Lisa Hood Chief People Officer | Nov 15, 2022 | Sale | −2,046 | $5.28 | $10.80K | 31,234 |
| Ken Gelhaus Chief Commercial Officer | Nov 14, 2022 | Buy | +1,422 | $4.23 | $6.02K | 1,422 |
| Lisa Hood Chief People Officer | Nov 14, 2022 | Buy | +2,046 | $4.23 | $8.65K | 33,280 |
| Stephen Gunstream President and CEO, Director | Nov 14, 2022 | Buy | +1,716 | $4.23 | $7.26K | 61,008 |
| Stephen Gunstream President and CEO, Director | Sep 30, 2022 | Option exercise | +40,000 | $0.84 | $33.60K | 58,000 |
| Matthew Lowell Chief Financial Officer | Sep 1, 2022 | Buy | +10,000 | $4.61 | $46.10K | 20,000 |
| J. Matthew Mackowski Director | Aug 24, 2022 | Buy | +5,000 | $4.97 | $24.85K | 5,000 |
| J. Matthew Mackowski Director | Aug 24, 2022 | Buy | +5,000 | $4.98 | $24.90K | 5,000 |
| Paul David Grossman Director | Aug 16, 2022 | Buy | +4,386 | $5.62 | $24.65K | 9,212 |
| Paul David Grossman Director | Aug 15, 2022 | Buy | +4,826 | $5.15 | $24.85K | 4,826 |
| Stephen Gunstream President and CEO, Director | Aug 15, 2022 | Buy | +18,000 | $5.13 | $92.34K | 18,000 |
| Brett Robertson Director | Jun 2, 2022 | Award | +9,357 | – | – | 9,357 |
| Alexander Vos Director | Jun 2, 2022 | Award | +9,357 | – | – | 9,357 |
| Robert McNamara Director | Jun 2, 2022 | Award | +9,357 | – | – | 9,357 |
| Matthew Lowell Chief Financial Officer | May 20, 2022 | Buy | +10,000 | $9.45 | $94.50K | 10,000 |
| Lisa Hood Chief People Officer | May 13, 2022 | Buy | +772 | $10.93 | $8.44K | 31,234 |
| Stephen Gunstream President and CEO, Director | May 13, 2022 | Buy | +1,292 | $10.93 | $14.12K | 1,292 |
| Lisa Hood Chief People Officer | Feb 4, 2022 | Option exercise | +30,462 | $1.85 | $56.35K | 30,462 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Lisa Hood Officer | Jun 13, 2023 | 11,400 | $43.27K | Jun 13, 2023 | EXERCISED SHARES |